153 related articles for article (PubMed ID: 35930535)
1. Clinical and biochemical predictors and predictive model of primary aldosteronism.
Manosroi W; Tacharearnmuang N; Atthakomol P
PLoS One; 2022; 17(8):e0272049. PubMed ID: 35930535
[TBL] [Abstract][Full Text] [Related]
2. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
3. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
[TBL] [Abstract][Full Text] [Related]
6. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
Yuan Y; Li N; Liu Y; Wang M; Heizhati M; Zhu Q; Yao X; Luo Q
Endocrine; 2022 Mar; 75(3):889-898. PubMed ID: 34780033
[TBL] [Abstract][Full Text] [Related]
7. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
8. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
Tanabe A; Naruse M; Takagi S; Tsuchiya K; Imaki T; Takano K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2489-94. PubMed ID: 12788844
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of primary aldosteronism in newly diagnosed diabetes mellitus with hypertensive patients.
Hu Y; Liu W; Zhang J; Su X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):923-928. PubMed ID: 33053533
[TBL] [Abstract][Full Text] [Related]
10. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
12. Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Umakoshi H; Sakamoto R; Matsuda Y; Yokomoto-Umakoshi M; Nagata H; Fukumoto T; Ogata M; Ogawa Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665338
[TBL] [Abstract][Full Text] [Related]
13. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
Hu Y; Zhang J; Liu W; Su X
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and validation of a nomogram-based predictive model for idiopathic aldosteronism].
Fei J; Shen H; Yang SM; Du ZP; Hu JB; Wang HB; Qin GJ; Ji HF; Li QF; Song Y
Zhonghua Nei Ke Za Zhi; 2023 Jun; 62(6):693-699. PubMed ID: 37263953
[No Abstract] [Full Text] [Related]
15. Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension.
Yan D; Zou X; Li X; Zeng Q; He H; Guo J; Wang Y; Zheng H; Fu J; Wang M; Peng D; Zhou X; Luo X; Luo J; Li S; Liu J; Hu P; Shen Y
Front Cardiovasc Med; 2024; 11():1383567. PubMed ID: 38720919
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
18. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
[TBL] [Abstract][Full Text] [Related]
19. [The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism].
Chen SH; Luo PY; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):134-141. PubMed ID: 33474903
[TBL] [Abstract][Full Text] [Related]
20. Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
Luo Q; Li N; Wang M; Yao X; Heizhati M; Zhang D; Zhou K; Wang G; Hu J; Zhu B
J Hum Hypertens; 2020 Sep; 34(9):633-640. PubMed ID: 31792441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
